Growing evidences have suggested that ET-1 plays an important role during various phases of CAD pathophysiology, contributing in early stages to endothelial dysfunction, inflammation, and atherosclerotic plaque formation [13,15,43]. The gene discussed is EDN1; the disease is endothelial dysfunction.